Current and Future Treatment Options for PBC, NASH and Hepatic Encephalopathy
The goal of this program is to improve healthcare providers competency in understanding the long-term effects and potential liver related complications of chronic liver diseases. The program will also provide education on management options and outcomes of treatment.
Jointly sponsored by
College of Pharmacy and
the Chronic Liver
Disease Foundation. This educational material was supported by a grant from Salix Pharmaceuticals.
Hepatic Encephalopathy Update: Reports from the 64th Annual Meeting of the American Association for the Study of Liver Diseases
This activity has been designed to meet the educational needs of hepatologists, gastroenterologists, physician assistants, and nurse practitioners involved in the care of patients with chronic liver disease.
Statement of Need/Program
To provide important clinical data on issues related to the management of hepatic encephalopathy.
Upon completion of this activity, participants should be better able to:
Recognize the currently available therapeutic options for hepatic encephalopathy, as well as challenges in diagnosing hepatic encephalopathy, particularly covert hepatic encephalopathy
Assess the results of selected studies relating to the diagnosis and treatment of hepatic encephalopathy presented at the 64th Annual Meeting of the American Association for the Study of Liver Diseases
Please see page 1 of the
newsletter for full